Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains

Jeroen J. Lammerts van Bueren; Theo Rispens; Sandra Verploegen; Tjitske van der Palen-Merkus; Steven Stapel; Lisa J. Workman; Hayley James; Patrick H. C. van Berkel; Jan G. J. van de Winkel; Thomas A. E. Platts-Mills; Paul W. H. I. Parren

doi:https://doi.org/10.1038/nbt.1912

Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains

Jeroen J. Lammerts van Bueren, Theo Rispens, Sandra Verploegen, Tjitske van der Palen-Merkus, Steven Stapel, Lisa J. Workman, Hayley James, Patrick H. C. van Berkel, Jan G. J. van de Winkel, Thomas A. E. Platts-Mills, Paul W. H. I. Parren

Landsteiner Laboratory (AMC)

Research output: Contribution to journal › Comment/Letter to the editor › Academic

102 Citations (Scopus)

Original language	English
Pages (from-to)	574-576
Journal	Nature biotechnology
Volume	29
Issue number	7
DOIs	https://doi.org/10.1038/nbt.1912
Publication status	Published - 2011

Access to Document

https://doi.org/10.1038/nbt.1912

Cite this

Lammerts van Bueren, J. J., Rispens, T., Verploegen, S., van der Palen-Merkus, T., Stapel, S., Workman, L. J., James, H., van Berkel, P. H. C., van de Winkel, J. G. J., Platts-Mills, T. A. E., & Parren, P. W. H. I. (2011). Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains. Nature biotechnology, 29(7), 574-576. https://doi.org/10.1038/nbt.1912

@article{125fdb46c7be41118647140ef786fd27,

title = "Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains",

author = "{Lammerts van Bueren}, {Jeroen J.} and Theo Rispens and Sandra Verploegen and {van der Palen-Merkus}, Tjitske and Steven Stapel and Workman, {Lisa J.} and Hayley James and {van Berkel}, {Patrick H. C.} and {van de Winkel}, {Jan G. J.} and Platts-Mills, {Thomas A. E.} and Parren, {Paul W. H. I.}",

year = "2011",

doi = "https://doi.org/10.1038/nbt.1912",

language = "English",

volume = "29",

pages = "574--576",

journal = "Nature biotechnology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "7",

}

Lammerts van Bueren, JJ, Rispens, T, Verploegen, S, van der Palen-Merkus, T, Stapel, S, Workman, LJ, James, H, van Berkel, PHC, van de Winkel, JGJ, Platts-Mills, TAE & Parren, PWHI 2011, 'Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains', Nature biotechnology, vol. 29, no. 7, pp. 574-576. https://doi.org/10.1038/nbt.1912

TY - JOUR

T1 - Anti-galactose-alpha-1,3-galactose IgE from allergic patients does not bind alpha-galactosylated glycans on intact therapeutic antibody Fc domains

AU - Lammerts van Bueren, Jeroen J.

AU - Rispens, Theo

AU - Verploegen, Sandra

AU - van der Palen-Merkus, Tjitske

AU - Stapel, Steven

AU - Workman, Lisa J.

AU - James, Hayley

AU - van Berkel, Patrick H. C.

AU - van de Winkel, Jan G. J.

AU - Platts-Mills, Thomas A. E.

AU - Parren, Paul W. H. I.

PY - 2011

Y1 - 2011

U2 - https://doi.org/10.1038/nbt.1912

DO - https://doi.org/10.1038/nbt.1912

M3 - Comment/Letter to the editor

C2 - 21747378

SN - 1087-0156

VL - 29

SP - 574

EP - 576

JO - Nature biotechnology

JF - Nature biotechnology

IS - 7

ER -